
Contact us
About company
Tomunnity Therapeutics Limited is an oncology-focused drug development company founded in 2019. Tomunnity developing 2nd generation anti-PD-L1 drug to satisfy unmet medical needs. Our team includes experts from North America and Asia, and we integrate various resources in USA and Taiwan to maximize our drug development efficiency.
Unknown
Unknown
Unknown
Not verified company